Market OverviewBacterial infections remain a persistent global health burden, and extended-release antibiotic formulations continue gaining favor for their improved dosing convenience. The Cefaclor Extended Release Tablet Market was valued at 700 USD Million in 2024 and is projected to grow from 800 USD Million in 2025 to 1,200 USD Million by 2035, at a CAGR of 4.4%. Current Market LandscapeThe...